TABLE 1.
Baseline study characteristics of single-micronutrient interventions in children ≥2 y of age1
Study | Year | Country | Subjects, n | Mean initial age, mo | Dose | Duration, mo | Mean initial HAZ | Quality |
Iron | ||||||||
Aguayo (10) | 2000 | Bolivia | 64 | 111 | 3 mg/kg bw | 4 | −1.48 | High |
Angeles et al. (11) | 1993 | Indonesia | 76 | 37 | 30 mg | 2 | −2.26 | Medium |
Bhatia and Seshadri 1 (12) | 1992 | India | 105 | 47 | 40 mg | 6 | −2.3 | Medium |
Bhatia and Seshadri 2 (12) | 1992 | India | 51 | 54 | 40 mg | 6 | −1.56 | Medium |
Chen et al. (13) | 2008 | China | 132 | 48 | 8.57 mg | 6 | −0.23 | Medium |
Chwang et al. (14) | 1988 | Indonesia | 41 | 128 | 10 mg/kg bw | 3 | −1.52 | Medium |
Dossa et al. (15) | 2001 | Benin | 68 | 47 | 60 mg | 3 | −2.26 | Medium |
Hettiarachchi et al. (16) | 2008 | Sri Lanka | 374 | 167 | 35.71 mg | 6 | −1.19 | Medium |
Latham et al. (17) | 1990 | Kenya | 55 | 96 | 285.7 mg | 1 | −0.88 | High |
Lawless et al. (18) | 1994 | Kenya | 86 | 105 | 150 mg | 3 | −1.23 | High |
Mwanri et al. 1 (19) | 2000 | Tanzania | 68 | 132 | 85.7 mg | 3 | −2.2 | High |
Mwanri et al. 2 (19) | 2000 | Tanzania | 68 | 126 | 85.7 mg | 3 | −1.56 | High |
Palupi et al. (20) | 1997 | Indonesia | 187 | 42 | 4.29 mg | 2 | −1.82 | Medium |
Pereira et al. (21) | 1979 | India | 44 | 42 | 10 mg | 5 | — | Low |
Rahman et al. (22) | 1999 | Bangladesh | 147 | 34 | 15 mg | 12 | −2.2 | High |
Sungthong et al. 1 (23) | 2002 | Thailand | 200 | 116 | 300 mg | 4 | −1.55 | High |
Sungthong et al. 2 (23) | 2002 | Thailand | 190 | 116 | 42.86 mg | 4 | −1.49 | High |
Zinc | ||||||||
Castillo-Durán et al. 1 (24) | 1994 | Chile | 19 | 169 | 10 mg | 12 | −2.58 | High |
Castillo-Durán et al. 2 (24) | 1994 | Chile | 18 | 138 | 10 mg | 12 | −2.61 | High |
Cavan et al. (25) | 1993 | Guatemala | 156 | 82 | 7.14 mg | 6 | −1.38 | High |
Friis et al. (26) | 1997 | Zimbabwe | 276 | 134 | 40 mg | 12 | −1.18 | High |
Gibson et al. (27) | 1989 | Canada | 60 | 75 | 10 mg | 12 | −1.39 | High |
Hettiarachchi et al. (16) | 2008 | Sri Lanka | 382 | 161 | 10 mg | 6 | −1.1 | High |
Kaseb and Fallah (28) | 2013 | Iran | 95 | 146 | 5 mg | 4 | −0.6 | High |
Kikafunda et al. (29) | 1998 | Uganda | 113 | 56 | 10 mg | 6 | −0.7 | High |
Mozaffari-Khosravi et al. 1 (30) | 2009 | Iran | 47 | 39 | 5 mg | 6 | −1.58 | Medium |
Mozaffari-Khosravi et al. 2 (30) | 2009 | Iran | 38 | 40 | 5 mg | 6 | −1.65 | Medium |
Nakamura et al. (31) | 1993 | Japan | 21 | 70 | 5 mg | 6 | −2.44 | Low |
Ronaghy et al. (32) | 1969 | Iran | 27 | 156 | 28 mg | 5 | −2.73 | Low |
Ronaghy et al. (33) | 1974 | Iran | 39 | 156 | 40 mg | 12 | −3.02 | Low |
Rosado et al. (34) | 1997 | Mexico | 95 | 29 | 20 mg | 12 | −1.7 | High |
Ruz et al. (35) | 1997 | Chile | 53 | 40 | 10 mg | 14 | −0.52 | High |
Sayeg Porto et al. (36) | 2000 | Brazil | 18 | 116 | 5 mg/kg bw | 6 | −2.67 | Medium |
Sempértegui et al. (37) | 1996 | Ecuador | 48 | 42 | 10 mg | 2 | −2 | High |
Taneja et al. (38) | 2010 | India | 421 | 27 | 20 mg | 4 | — | High |
Walravens et al. (39) | 1983 | United States | 40 | 50 | 10 mg | 12 | −2.07 | High |
Calcium | ||||||||
Bass et al. 1 (40) | 2007 | Australia | 47 | 109 | 800 mg | 9 | 0.47 | High |
Bass et al. 2 (40) | 2007 | Australia | 41 | 109 | 800 mg | 9 | 0.36 | High |
Bonjour et al. (41) | 1997 | Switzerland | 108 | 95 | 850 mg | 12 | 0.3 | High |
Cameron et al. (42) | 2004 | Australia | 48 | 124 | 1200 mg | 24 | 0.3 | High |
Chevalley et al. (43) | 2005 | Switzerland | 174 | 89.3 | 850 mg | 12 | 0.2 | High |
Courteix et al. 1 (44) | 2005 | France | 54 | 119.3 | 800 mg | 12 | — | High |
Courteix et al. 2 (44) | 2005 | France | 31 | 119.3 | 800 mg | 12 | — | High |
Dibba et al. (45) | 2000 | Gambia | 160 | 124 | 714.3 mg | 12 | −1.09 | High |
Ekbote et al. (46) | 2011 | India | 58 | 33 | 357.1 mg | 12 | −1.96 | High |
Iuliano-Burns et al. 1 (47) | 2003 | Australia | 34 | 106 | 434 mg | 9 | −0.08 | High |
Iuliano-Burns et al. 2 (47) | 2003 | Australia | 32 | 106 | 434 mg | 9 | 0.27 | High |
Lloyd et al. (48) | 1993 | United States | 94 | 143 | 500 mg | 18 | −0.23 | High |
Nowson et al. (49) | 1997 | Australia | 56 | 168 | 1000 mg | 18 | −0.9 | High |
Pettifor et al. (50) | 1981 | South Africa | 60 | 121 | 500 mg | 3 | −1.09 | Medium |
Specker and Binkley 1 (51) | 2003 | United States | 90 | 48 | 714.3 mg | 12 | 0 | High |
Specker and Binkley 2 (51) | 2003 | United States | 88 | 39 | 714.3 mg | 12 | −0.15 | High |
Iodine | ||||||||
Zimmerman et al. 1 (52) | 2007 | Albania | 310 | 137 | 400 mg2 | 6 | −1.13 | Medium |
Zimmerman et al. 2 (52) | 2007 | South Africa | 188 | 110 | 200 mg3 | 6 | −0.54 | Medium |
Vitamin A | ||||||||
Fawzi et al. 1 (53) | 1997 | Sudan | 2166 | 24 to <364 | 200,000 IU | 17 | — | High |
Fawzi et al. 2 (53) | 1997 | Sudan | 2033 | 36 to <484 | 200,000 IU | 17 | — | High |
Fawzi et al. 3 (53) | 1997 | Sudan | 1975 | 48 to <604 | 200,000 IU | 17 | — | High |
Fawzi et al. 4 (53) | 1997 | Sudan | 1756 | 60 to <724 | 200,000 IU | 17 | — | High |
Fawzi et al. 5 (53) | 1997 | Sudan | 2079 | >604 | 200,000 IU | 17 | — | High |
Fawzi et al. 6 (53) | 1997 | Sudan | 1991 | 24 to <364 | 200,000 IU | 17 | — | High |
Fawzi et al. 7 (53) | 1997 | Sudan | 2023 | 36 to <484 | 200,000 IU | 17 | — | High |
Fawzi et al. 8 (53) | 1997 | Sudan | 1985 | 48 to <604 | 200,000 IU | 17 | — | High |
Fawzi et al. 9 (53) | 1997 | Sudan | 1875 | 60 to <724 | 200,000 IU | 17 | — | High |
Fawzi et al. 10 (53) | 1997 | Sudan | 2120 | >604 | 200,000 IU | 17 | — | High |
Hadi et al. 1 (54) | 2000 | Indonesia | 377 | ≥244 | 206,000 IU | 24 | — | Medium |
Hadi et al. 2 (54) | 2000 | Indonesia | 2263 | ≥244 | 206,000 IU | 24 | — | Medium |
Lin et al. (55) | 2009 | China | 86 | 37 | 100,000 IU | 3 | −0.46 | High |
Mwanri et al. 1(19) | 2000 | Tanzania | 68 | 131 | 5000 IU | 3 | −2.13 | High |
Mwanri et al. 2 (19) | 2000 | Tanzania | 68 | 127 | 5000 IU | 3 | −1.39 | High |
Yang et al. (56) | 2002 | China | 63 | 48 | 667 IU | 12 | −1.55 | High |
bw, body weight; HAZ, height-for-age z score; IU, international unit.
Single dose.
Two doses delivered 3 mo apart.
Age range.